Montisera Ltd (Montisera) is a virtual discovery company. Alongside of the development of its own bioactive molecules, Montisera is offering novel project based funding opportunities for investors in asset development programs. These assets are licensed or acquired to Montisera, and via funding programs, the original owner of the compounds, investors, and further the new owner of the compounds will benefit from the successfully executed development projects.
Montisera provides customers fast, reliable and cost-effective way to develop molecules. Montisera's goal is to be one of the pioneers applying flexible virtual development model in bioactive compound development.
No development company is able to profit alone, we should rather profit together.
Company Details
- Employees
- 6
- Founded
- -
- Address
- Tekniikantie, Innopoli 2,finland
- Phone
- 358407562427
- in****@****era.com
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- montisera.com
- Keywords
- Finnish innovations in health sciences, Project based funding opportunities, Drug development, Bioeconomy, Food ingredients, Networking, Health, Bioactive.
- HQ
- Espoo, Uusimaa
Montisera Ltd Questions
Montisera Ltd's helpline number is 358407562427
Montisera Ltd's website is montisera.com
Montisera Ltd's LinkedIn profile is https://fi.linkedin.com/company/montisera-ltd-
Montisera Ltd has
6 employees.
View email and phone details for 6
employees at Montisera Ltd.
Montisera Ltd's industry is
Pharmaceutical Manufacturing
Montisera Ltd's top competitors are
Rebio,
True Wealth,
Preclinapps,
Scr Capital Investments,
Finnpatent Oy,
Bioproton,
7ense,
Kestools Oy,
Smart Chemistry Park,
Business Turku.
Montisera Ltd's support email address is info@montisera.com
Montisera Ltd's categories are Pharmaceutical Manufacturing
Montisera Ltd's founding year is 2012
